Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Explore the question of which is better for daily expenses: cash back or points. Make informed choices to maximize your rewards potential.
27,346 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Roth IRA Strategies: Tax-Free Growth for Your Future unlocks a tax-smart path to retirement. Learn practical tactics,...
Jamie Dimon has warned that certain stablecoin rules could destabilize financial markets. This article breaks down th...
As job cuts persist in early 2026, employers cite AI adoption to explain restructuring. The trend underscores why wor...
Morgan Stanley reveals a sharper cost curve for AI data centers, suggesting only a few players can fund the next wave...
California, Texas, and New York led WWII enlistment among U.S. states, with figures shaped by population and industry...
Retirees with a $2 million 401(K) who buy a QLAC may shift their RMDs, potentially triggering higher tax rates and Me...
If you’re dreaming of a bigger Social Security check in 2026, you’ll want a plan that blends earnings, timing, and sm...
A new class of buffer ETFs promises protection for the first 15% of losses while chasing stock gains without stress? ...
Fed chair Powell kept policy steady as he hailed resilience in the U.S. economy, while warning that inflation and ene...
A new PWBM study places the insolvency deadline for Social Security's trust fund at 2032, six years from now. It eval...
XPeng reported a rare quarterly profit in Q4 2025 but warned of a softer start to 2026, sending shares lower as inves...